RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ:IRTC) securities during the period from August 4, 2020 through January 28, 2021, inclusive (the “Class Period”).
iRhythm shareholders may, no later than April 2, 2021, move the Court for appointment as a lead plaintiff of the Class. If you purchased shares of iRhythm and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here.
According to the Complaint, the Company made false and misleading statements to the market. U.S. Centers for Medicare and Medicaid Services' ("CMS") rulemaking caused iRhythm's business to suffer. The Company's reimbursement rates plummeted as a result. Further uncertainty and weakness in the Company's business was caused by a lack of national pricing in the CMS rule and fee schedule. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about iRhythm, investors suffered damages.
If you are a member of the class, you may, no later than April 2, 2021, request that the Court appoint you as lead plaintiff of the class. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Under certain circumstances, one or more class members may together serve as "lead plaintiff." Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain RM LAW, P.C. or other counsel of your choice, to serve as your counsel in this action.